Abstract
Objective Acute rejection may lead to cell death following heart transplantation. Programmed cell death (apoptosis) has been described as a cofactor for cell loss in cardiac tissue. The aim of our study was to quantify the amount and extent of apoptotic cells during acute rejection episodes after orthotopic heart transplantation. Patients and Methods Right ventricular biopsies from 27 heart transplant recipients were classified histologically according to rejection grade. Formalin-fixed sections were processed for immunohistochemistry. TUNEL-positive cells were counted and the expression of apoptosis-modulating factors Bax, Bcl-x L, Bcl-2, and Ki-67 (proliferation marker) was scored. P ≤ .05 was considered statistically significant. Results The total amount of TUNEL-positive interstitial cells was 1.5/mm 2 and 1/mm 2 for cardiomyocytes. The number of TUNEL-positive interstitial cells was found to be significantly higher in high-grade rejection. The anti-apoptotic Bcl-2 was expressed significantly higher in interstitial cells during high-grade rejection, whereas in cardiomyocytes there were no differences regarding Bcl-2 expression. There were no significant differences in the expression of Bcl-x L and Bax. The proliferation marker Ki-67 was not positive in cardiomyocytes. In interstitial cells the expression did not differ between low-and high-grade rejection. Conclusions The current study demonstrated the presence of apoptotic cell death during acute rejection episodes in human heart transplants. Interstitial cells were affected almost exclusively, whereas apoptosis of cardiomyocytes was hardly detectable. However, the amount of apoptotic cells was too low to have a significant impact on organ function. Moreover, the anti-apoptotic Bcl-2 could be found in interstitial cells and seemed to have an apoptosis-protective effect in acute high-grade rejection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
